Revance Therapeutics (NASDAQ: RVNC) to Go Private in $924 Million Acquisition Deal
Anti-wrinkle injection maker Revance Therapeutics (NASDAQ: RVNC) has agreed to be bought by privately held Crown Laboratories in a deal […]
Revance Therapeutics (NASDAQ: RVNC) to Go Private in $924 Million Acquisition Deal Read More »
